FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Sumatriptan Succinate Injection
Status: Discontinuation
»Therapeutic Categories: Neurology

Expand all

Mylan Institutional (New 02/21/2020)

Company Contact Information:
800-796-9526

Presentation Posting Date Related Information
6 mg/0.5 mL, single-dose vial (NDC 67457-880-05) 02/21/2020 Expected discontinuation August 2020 (short dating)

Teva Pharmaceuticals (New 12/05/2019)

Company Contact Information:
800-545-8800

Presentation Posting Date Related Information
6 mg/0.5 mL (NDC 0703-7351-01) 12/05/2019

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English